nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0838	0.11	CbGbCtD
Diltiazem—CYP3A7—Progesterone—uterine cancer	0.077	0.101	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.077	0.101	CbGbCtD
Diltiazem—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0584	0.0769	CbGbCtD
Diltiazem—CYP3A5—Progesterone—uterine cancer	0.0577	0.0759	CbGbCtD
Diltiazem—CYP2C8—Progesterone—uterine cancer	0.0555	0.073	CbGbCtD
Diltiazem—CYP2C19—Progesterone—uterine cancer	0.0466	0.0612	CbGbCtD
Diltiazem—CYP2C9—Progesterone—uterine cancer	0.0387	0.0509	CbGbCtD
Diltiazem—ABCB1—Progesterone—uterine cancer	0.0376	0.0494	CbGbCtD
Diltiazem—CYP2D6—Progesterone—uterine cancer	0.0354	0.0466	CbGbCtD
Diltiazem—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.034	0.0447	CbGbCtD
Diltiazem—ABCB1—Dactinomycin—uterine cancer	0.0298	0.0392	CbGbCtD
Diltiazem—CYP3A5—Etoposide—uterine cancer	0.0258	0.034	CbGbCtD
Diltiazem—CYP2C8—Etoposide—uterine cancer	0.0248	0.0327	CbGbCtD
Diltiazem—CYP3A4—Progesterone—uterine cancer	0.0225	0.0296	CbGbCtD
Diltiazem—ABCB1—Etoposide—uterine cancer	0.0168	0.0221	CbGbCtD
Diltiazem—ABCB1—Doxorubicin—uterine cancer	0.0115	0.0151	CbGbCtD
Diltiazem—CYP2D6—Doxorubicin—uterine cancer	0.0108	0.0142	CbGbCtD
Diltiazem—CYP3A4—Etoposide—uterine cancer	0.0101	0.0133	CbGbCtD
Diltiazem—CYP3A4—Doxorubicin—uterine cancer	0.00687	0.00904	CbGbCtD
Diltiazem—Feeling abnormal—Dactinomycin—uterine cancer	0.000239	0.00103	CcSEcCtD
Diltiazem—Ill-defined disorder—Etoposide—uterine cancer	0.000239	0.00103	CcSEcCtD
Diltiazem—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00102	CcSEcCtD
Diltiazem—Affect lability—Epirubicin—uterine cancer	0.000236	0.00102	CcSEcCtD
Diltiazem—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000235	0.00101	CcSEcCtD
Diltiazem—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00101	CcSEcCtD
Diltiazem—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00101	CcSEcCtD
Diltiazem—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.001	CcSEcCtD
Diltiazem—Malaise—Etoposide—uterine cancer	0.000232	0.001	CcSEcCtD
Diltiazem—Face oedema—Epirubicin—uterine cancer	0.000232	0.000996	CcSEcCtD
Diltiazem—Vertigo—Etoposide—uterine cancer	0.000231	0.000996	CcSEcCtD
Diltiazem—Leukopenia—Etoposide—uterine cancer	0.000231	0.000993	CcSEcCtD
Diltiazem—Purpura—Doxorubicin—uterine cancer	0.00023	0.000991	CcSEcCtD
Diltiazem—Body temperature increased—Dactinomycin—uterine cancer	0.00023	0.000988	CcSEcCtD
Diltiazem—Abdominal pain—Dactinomycin—uterine cancer	0.00023	0.000988	CcSEcCtD
Diltiazem—Cardiac arrest—Epirubicin—uterine cancer	0.000228	0.000981	CcSEcCtD
Diltiazem—Mood swings—Epirubicin—uterine cancer	0.000227	0.000978	CcSEcCtD
Diltiazem—Loss of consciousness—Etoposide—uterine cancer	0.000226	0.000975	CcSEcCtD
Diltiazem—Lethargy—Doxorubicin—uterine cancer	0.000226	0.000975	CcSEcCtD
Diltiazem—Cough—Etoposide—uterine cancer	0.000225	0.000968	CcSEcCtD
Diltiazem—Osteoarthritis—Doxorubicin—uterine cancer	0.000222	0.000955	CcSEcCtD
Diltiazem—Diplopia—Doxorubicin—uterine cancer	0.000222	0.000955	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000222	0.000955	CcSEcCtD
Diltiazem—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000221	0.000952	CcSEcCtD
Diltiazem—Chest pain—Etoposide—uterine cancer	0.000219	0.000944	CcSEcCtD
Diltiazem—Abdominal pain upper—Epirubicin—uterine cancer	0.000219	0.000943	CcSEcCtD
Diltiazem—Orthostatic hypotension—Epirubicin—uterine cancer	0.000219	0.000943	CcSEcCtD
Diltiazem—Affect lability—Doxorubicin—uterine cancer	0.000218	0.00094	CcSEcCtD
Diltiazem—Discomfort—Etoposide—uterine cancer	0.000217	0.000933	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000216	0.000929	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000216	0.000929	CcSEcCtD
Diltiazem—Nasopharyngitis—Epirubicin—uterine cancer	0.000214	0.000923	CcSEcCtD
Diltiazem—Face oedema—Doxorubicin—uterine cancer	0.000214	0.000922	CcSEcCtD
Diltiazem—Hypersensitivity—Dactinomycin—uterine cancer	0.000214	0.000921	CcSEcCtD
Diltiazem—Cardiac arrest—Doxorubicin—uterine cancer	0.000211	0.000908	CcSEcCtD
Diltiazem—Mood swings—Doxorubicin—uterine cancer	0.00021	0.000905	CcSEcCtD
Diltiazem—Infection—Etoposide—uterine cancer	0.000209	0.000899	CcSEcCtD
Diltiazem—Abdominal distension—Epirubicin—uterine cancer	0.000209	0.000898	CcSEcCtD
Diltiazem—Asthenia—Dactinomycin—uterine cancer	0.000208	0.000897	CcSEcCtD
Diltiazem—Influenza—Epirubicin—uterine cancer	0.000207	0.000892	CcSEcCtD
Diltiazem—Thrombocytopenia—Etoposide—uterine cancer	0.000206	0.000886	CcSEcCtD
Diltiazem—Tachycardia—Etoposide—uterine cancer	0.000205	0.000883	CcSEcCtD
Diltiazem—Hyperhidrosis—Etoposide—uterine cancer	0.000203	0.000875	CcSEcCtD
Diltiazem—Abdominal pain upper—Doxorubicin—uterine cancer	0.000203	0.000872	CcSEcCtD
Diltiazem—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000203	0.000872	CcSEcCtD
Diltiazem—Anorexia—Etoposide—uterine cancer	0.0002	0.000863	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.0002	0.00086	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.0002	0.00086	CcSEcCtD
Diltiazem—Bronchitis—Epirubicin—uterine cancer	0.000199	0.000858	CcSEcCtD
Diltiazem—Diarrhoea—Dactinomycin—uterine cancer	0.000199	0.000856	CcSEcCtD
Diltiazem—Nasopharyngitis—Doxorubicin—uterine cancer	0.000198	0.000854	CcSEcCtD
Diltiazem—Hypotension—Etoposide—uterine cancer	0.000197	0.000846	CcSEcCtD
Diltiazem—Abdominal distension—Doxorubicin—uterine cancer	0.000193	0.000831	CcSEcCtD
Diltiazem—Influenza—Doxorubicin—uterine cancer	0.000192	0.000825	CcSEcCtD
Diltiazem—Pollakiuria—Epirubicin—uterine cancer	0.000191	0.000824	CcSEcCtD
Diltiazem—Photosensitivity reaction—Epirubicin—uterine cancer	0.000189	0.000814	CcSEcCtD
Diltiazem—Paraesthesia—Etoposide—uterine cancer	0.000189	0.000813	CcSEcCtD
Diltiazem—Weight increased—Epirubicin—uterine cancer	0.000189	0.000812	CcSEcCtD
Diltiazem—Dyspnoea—Etoposide—uterine cancer	0.000187	0.000807	CcSEcCtD
Diltiazem—Hyperglycaemia—Epirubicin—uterine cancer	0.000187	0.000805	CcSEcCtD
Diltiazem—Somnolence—Etoposide—uterine cancer	0.000187	0.000805	CcSEcCtD
Diltiazem—Vomiting—Dactinomycin—uterine cancer	0.000185	0.000795	CcSEcCtD
Diltiazem—Bronchitis—Doxorubicin—uterine cancer	0.000184	0.000794	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000183	0.000789	CcSEcCtD
Diltiazem—Rash—Dactinomycin—uterine cancer	0.000183	0.000788	CcSEcCtD
Diltiazem—Decreased appetite—Etoposide—uterine cancer	0.000183	0.000787	CcSEcCtD
Diltiazem—Renal failure—Epirubicin—uterine cancer	0.000182	0.000782	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Etoposide—uterine cancer	0.000182	0.000781	CcSEcCtD
Diltiazem—Fatigue—Etoposide—uterine cancer	0.000181	0.00078	CcSEcCtD
Diltiazem—Neuropathy peripheral—Epirubicin—uterine cancer	0.000181	0.00078	CcSEcCtD
Diltiazem—Constipation—Etoposide—uterine cancer	0.00018	0.000774	CcSEcCtD
Diltiazem—Pain—Etoposide—uterine cancer	0.00018	0.000774	CcSEcCtD
Diltiazem—Urinary tract infection—Epirubicin—uterine cancer	0.00018	0.000773	CcSEcCtD
Diltiazem—Conjunctivitis—Epirubicin—uterine cancer	0.00018	0.000773	CcSEcCtD
Diltiazem—Sweating—Epirubicin—uterine cancer	0.000177	0.000763	CcSEcCtD
Diltiazem—Pollakiuria—Doxorubicin—uterine cancer	0.000177	0.000763	CcSEcCtD
Diltiazem—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000175	0.000753	CcSEcCtD
Diltiazem—Weight increased—Doxorubicin—uterine cancer	0.000175	0.000751	CcSEcCtD
Diltiazem—Epistaxis—Epirubicin—uterine cancer	0.000174	0.00075	CcSEcCtD
Diltiazem—Sinusitis—Epirubicin—uterine cancer	0.000173	0.000746	CcSEcCtD
Diltiazem—Feeling abnormal—Etoposide—uterine cancer	0.000173	0.000746	CcSEcCtD
Diltiazem—Hyperglycaemia—Doxorubicin—uterine cancer	0.000173	0.000745	CcSEcCtD
Diltiazem—Nausea—Dactinomycin—uterine cancer	0.000173	0.000743	CcSEcCtD
Diltiazem—Agranulocytosis—Epirubicin—uterine cancer	0.000172	0.000742	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00017	0.00073	CcSEcCtD
Diltiazem—Bradycardia—Epirubicin—uterine cancer	0.000169	0.000727	CcSEcCtD
Diltiazem—Renal failure—Doxorubicin—uterine cancer	0.000168	0.000723	CcSEcCtD
Diltiazem—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000168	0.000721	CcSEcCtD
Diltiazem—Urticaria—Etoposide—uterine cancer	0.000167	0.000719	CcSEcCtD
Diltiazem—Rhinitis—Epirubicin—uterine cancer	0.000166	0.000716	CcSEcCtD
Diltiazem—Body temperature increased—Etoposide—uterine cancer	0.000166	0.000715	CcSEcCtD
Diltiazem—Abdominal pain—Etoposide—uterine cancer	0.000166	0.000715	CcSEcCtD
Diltiazem—Urinary tract infection—Doxorubicin—uterine cancer	0.000166	0.000715	CcSEcCtD
Diltiazem—Conjunctivitis—Doxorubicin—uterine cancer	0.000166	0.000715	CcSEcCtD
Diltiazem—Hepatitis—Epirubicin—uterine cancer	0.000166	0.000714	CcSEcCtD
Diltiazem—Pharyngitis—Epirubicin—uterine cancer	0.000165	0.000709	CcSEcCtD
Diltiazem—Sweating—Doxorubicin—uterine cancer	0.000164	0.000706	CcSEcCtD
Diltiazem—Urinary tract disorder—Epirubicin—uterine cancer	0.000164	0.000705	CcSEcCtD
Diltiazem—Oedema peripheral—Epirubicin—uterine cancer	0.000163	0.000703	CcSEcCtD
Diltiazem—Urethral disorder—Epirubicin—uterine cancer	0.000163	0.0007	CcSEcCtD
Diltiazem—Epistaxis—Doxorubicin—uterine cancer	0.000161	0.000694	CcSEcCtD
Diltiazem—Sinusitis—Doxorubicin—uterine cancer	0.00016	0.00069	CcSEcCtD
Diltiazem—Visual impairment—Epirubicin—uterine cancer	0.00016	0.000688	CcSEcCtD
Diltiazem—Agranulocytosis—Doxorubicin—uterine cancer	0.00016	0.000687	CcSEcCtD
Diltiazem—Erythema multiforme—Epirubicin—uterine cancer	0.000157	0.000675	CcSEcCtD
Diltiazem—Bradycardia—Doxorubicin—uterine cancer	0.000156	0.000673	CcSEcCtD
Diltiazem—Eye disorder—Epirubicin—uterine cancer	0.000155	0.000667	CcSEcCtD
Diltiazem—Hypersensitivity—Etoposide—uterine cancer	0.000155	0.000667	CcSEcCtD
Diltiazem—Tinnitus—Epirubicin—uterine cancer	0.000155	0.000666	CcSEcCtD
Diltiazem—Flushing—Epirubicin—uterine cancer	0.000154	0.000663	CcSEcCtD
Diltiazem—Cardiac disorder—Epirubicin—uterine cancer	0.000154	0.000663	CcSEcCtD
Diltiazem—Rhinitis—Doxorubicin—uterine cancer	0.000154	0.000662	CcSEcCtD
Diltiazem—Hepatitis—Doxorubicin—uterine cancer	0.000154	0.000661	CcSEcCtD
Diltiazem—Pharyngitis—Doxorubicin—uterine cancer	0.000152	0.000656	CcSEcCtD
Diltiazem—Urinary tract disorder—Doxorubicin—uterine cancer	0.000152	0.000652	CcSEcCtD
Diltiazem—Oedema peripheral—Doxorubicin—uterine cancer	0.000151	0.000651	CcSEcCtD
Diltiazem—Asthenia—Etoposide—uterine cancer	0.000151	0.000649	CcSEcCtD
Diltiazem—Angiopathy—Epirubicin—uterine cancer	0.000151	0.000648	CcSEcCtD
Diltiazem—Urethral disorder—Doxorubicin—uterine cancer	0.00015	0.000648	CcSEcCtD
Diltiazem—Mediastinal disorder—Epirubicin—uterine cancer	0.00015	0.000644	CcSEcCtD
Diltiazem—Pruritus—Etoposide—uterine cancer	0.000149	0.00064	CcSEcCtD
Diltiazem—Arrhythmia—Epirubicin—uterine cancer	0.000148	0.000638	CcSEcCtD
Diltiazem—Visual impairment—Doxorubicin—uterine cancer	0.000148	0.000637	CcSEcCtD
Diltiazem—Alopecia—Epirubicin—uterine cancer	0.000147	0.000631	CcSEcCtD
Diltiazem—Erythema multiforme—Doxorubicin—uterine cancer	0.000145	0.000625	CcSEcCtD
Diltiazem—Erythema—Epirubicin—uterine cancer	0.000144	0.000622	CcSEcCtD
Diltiazem—Malnutrition—Epirubicin—uterine cancer	0.000144	0.000622	CcSEcCtD
Diltiazem—Diarrhoea—Etoposide—uterine cancer	0.000144	0.000619	CcSEcCtD
Diltiazem—Eye disorder—Doxorubicin—uterine cancer	0.000143	0.000617	CcSEcCtD
Diltiazem—Tinnitus—Doxorubicin—uterine cancer	0.000143	0.000616	CcSEcCtD
Diltiazem—Flushing—Doxorubicin—uterine cancer	0.000142	0.000613	CcSEcCtD
Diltiazem—Cardiac disorder—Doxorubicin—uterine cancer	0.000142	0.000613	CcSEcCtD
Diltiazem—Flatulence—Epirubicin—uterine cancer	0.000142	0.000612	CcSEcCtD
Diltiazem—Tension—Epirubicin—uterine cancer	0.000142	0.00061	CcSEcCtD
Diltiazem—Dysgeusia—Epirubicin—uterine cancer	0.000141	0.000609	CcSEcCtD
Diltiazem—Nervousness—Epirubicin—uterine cancer	0.00014	0.000604	CcSEcCtD
Diltiazem—Angiopathy—Doxorubicin—uterine cancer	0.000139	0.000599	CcSEcCtD
Diltiazem—Dizziness—Etoposide—uterine cancer	0.000139	0.000598	CcSEcCtD
Diltiazem—Muscle spasms—Epirubicin—uterine cancer	0.000139	0.000598	CcSEcCtD
Diltiazem—Mediastinal disorder—Doxorubicin—uterine cancer	0.000138	0.000595	CcSEcCtD
Diltiazem—Arrhythmia—Doxorubicin—uterine cancer	0.000137	0.00059	CcSEcCtD
Diltiazem—Vision blurred—Epirubicin—uterine cancer	0.000136	0.000586	CcSEcCtD
Diltiazem—Alopecia—Doxorubicin—uterine cancer	0.000136	0.000584	CcSEcCtD
Diltiazem—Ill-defined disorder—Epirubicin—uterine cancer	0.000134	0.000577	CcSEcCtD
Diltiazem—Vomiting—Etoposide—uterine cancer	0.000134	0.000575	CcSEcCtD
Diltiazem—Malnutrition—Doxorubicin—uterine cancer	0.000134	0.000575	CcSEcCtD
Diltiazem—Erythema—Doxorubicin—uterine cancer	0.000134	0.000575	CcSEcCtD
Diltiazem—Rash—Etoposide—uterine cancer	0.000133	0.000571	CcSEcCtD
Diltiazem—Dermatitis—Etoposide—uterine cancer	0.000132	0.00057	CcSEcCtD
Diltiazem—Headache—Etoposide—uterine cancer	0.000132	0.000567	CcSEcCtD
Diltiazem—Flatulence—Doxorubicin—uterine cancer	0.000132	0.000567	CcSEcCtD
Diltiazem—Tension—Doxorubicin—uterine cancer	0.000131	0.000564	CcSEcCtD
Diltiazem—Dysgeusia—Doxorubicin—uterine cancer	0.000131	0.000563	CcSEcCtD
Diltiazem—Malaise—Epirubicin—uterine cancer	0.00013	0.000561	CcSEcCtD
Diltiazem—Nervousness—Doxorubicin—uterine cancer	0.00013	0.000559	CcSEcCtD
Diltiazem—Vertigo—Epirubicin—uterine cancer	0.00013	0.000558	CcSEcCtD
Diltiazem—Syncope—Epirubicin—uterine cancer	0.00013	0.000557	CcSEcCtD
Diltiazem—Leukopenia—Epirubicin—uterine cancer	0.000129	0.000556	CcSEcCtD
Diltiazem—Muscle spasms—Doxorubicin—uterine cancer	0.000128	0.000553	CcSEcCtD
Diltiazem—Palpitations—Epirubicin—uterine cancer	0.000128	0.000549	CcSEcCtD
Diltiazem—Loss of consciousness—Epirubicin—uterine cancer	0.000127	0.000546	CcSEcCtD
Diltiazem—Cough—Epirubicin—uterine cancer	0.000126	0.000542	CcSEcCtD
Diltiazem—Vision blurred—Doxorubicin—uterine cancer	0.000126	0.000542	CcSEcCtD
Diltiazem—Nausea—Etoposide—uterine cancer	0.000125	0.000538	CcSEcCtD
Diltiazem—Ill-defined disorder—Doxorubicin—uterine cancer	0.000124	0.000534	CcSEcCtD
Diltiazem—Chest pain—Epirubicin—uterine cancer	0.000123	0.000529	CcSEcCtD
Diltiazem—Arthralgia—Epirubicin—uterine cancer	0.000123	0.000529	CcSEcCtD
Diltiazem—Myalgia—Epirubicin—uterine cancer	0.000123	0.000529	CcSEcCtD
Diltiazem—Discomfort—Epirubicin—uterine cancer	0.000121	0.000523	CcSEcCtD
Diltiazem—Malaise—Doxorubicin—uterine cancer	0.000121	0.000519	CcSEcCtD
Diltiazem—Dry mouth—Epirubicin—uterine cancer	0.00012	0.000518	CcSEcCtD
Diltiazem—Vertigo—Doxorubicin—uterine cancer	0.00012	0.000517	CcSEcCtD
Diltiazem—Syncope—Doxorubicin—uterine cancer	0.00012	0.000516	CcSEcCtD
Diltiazem—Leukopenia—Doxorubicin—uterine cancer	0.00012	0.000515	CcSEcCtD
Diltiazem—Palpitations—Doxorubicin—uterine cancer	0.000118	0.000508	CcSEcCtD
Diltiazem—Oedema—Epirubicin—uterine cancer	0.000118	0.000507	CcSEcCtD
Diltiazem—Loss of consciousness—Doxorubicin—uterine cancer	0.000117	0.000505	CcSEcCtD
Diltiazem—Infection—Epirubicin—uterine cancer	0.000117	0.000504	CcSEcCtD
Diltiazem—Cough—Doxorubicin—uterine cancer	0.000117	0.000502	CcSEcCtD
Diltiazem—Shock—Epirubicin—uterine cancer	0.000116	0.000499	CcSEcCtD
Diltiazem—Nervous system disorder—Epirubicin—uterine cancer	0.000116	0.000497	CcSEcCtD
Diltiazem—Thrombocytopenia—Epirubicin—uterine cancer	0.000115	0.000497	CcSEcCtD
Diltiazem—Tachycardia—Epirubicin—uterine cancer	0.000115	0.000495	CcSEcCtD
Diltiazem—Hyperhidrosis—Epirubicin—uterine cancer	0.000114	0.00049	CcSEcCtD
Diltiazem—Chest pain—Doxorubicin—uterine cancer	0.000114	0.00049	CcSEcCtD
Diltiazem—Arthralgia—Doxorubicin—uterine cancer	0.000114	0.00049	CcSEcCtD
Diltiazem—Myalgia—Doxorubicin—uterine cancer	0.000114	0.00049	CcSEcCtD
Diltiazem—Discomfort—Doxorubicin—uterine cancer	0.000112	0.000484	CcSEcCtD
Diltiazem—Anorexia—Epirubicin—uterine cancer	0.000112	0.000484	CcSEcCtD
Diltiazem—Dry mouth—Doxorubicin—uterine cancer	0.000111	0.000479	CcSEcCtD
Diltiazem—Hypotension—Epirubicin—uterine cancer	0.00011	0.000474	CcSEcCtD
Diltiazem—Oedema—Doxorubicin—uterine cancer	0.000109	0.000469	CcSEcCtD
Diltiazem—Infection—Doxorubicin—uterine cancer	0.000108	0.000466	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000107	0.000462	CcSEcCtD
Diltiazem—Shock—Doxorubicin—uterine cancer	0.000107	0.000462	CcSEcCtD
Diltiazem—Nervous system disorder—Doxorubicin—uterine cancer	0.000107	0.00046	CcSEcCtD
Diltiazem—Thrombocytopenia—Doxorubicin—uterine cancer	0.000107	0.00046	CcSEcCtD
Diltiazem—Insomnia—Epirubicin—uterine cancer	0.000107	0.000459	CcSEcCtD
Diltiazem—Tachycardia—Doxorubicin—uterine cancer	0.000106	0.000458	CcSEcCtD
Diltiazem—Paraesthesia—Epirubicin—uterine cancer	0.000106	0.000456	CcSEcCtD
Diltiazem—Hyperhidrosis—Doxorubicin—uterine cancer	0.000105	0.000454	CcSEcCtD
Diltiazem—Dyspnoea—Epirubicin—uterine cancer	0.000105	0.000452	CcSEcCtD
Diltiazem—Somnolence—Epirubicin—uterine cancer	0.000105	0.000451	CcSEcCtD
Diltiazem—Anorexia—Doxorubicin—uterine cancer	0.000104	0.000447	CcSEcCtD
Diltiazem—Dyspepsia—Epirubicin—uterine cancer	0.000104	0.000447	CcSEcCtD
Diltiazem—Decreased appetite—Epirubicin—uterine cancer	0.000102	0.000441	CcSEcCtD
Diltiazem—Hypotension—Doxorubicin—uterine cancer	0.000102	0.000439	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000102	0.000438	CcSEcCtD
Diltiazem—Fatigue—Epirubicin—uterine cancer	0.000102	0.000437	CcSEcCtD
Diltiazem—Constipation—Epirubicin—uterine cancer	0.000101	0.000434	CcSEcCtD
Diltiazem—Pain—Epirubicin—uterine cancer	0.000101	0.000434	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.94e-05	0.000428	CcSEcCtD
Diltiazem—Insomnia—Doxorubicin—uterine cancer	9.86e-05	0.000425	CcSEcCtD
Diltiazem—Paraesthesia—Doxorubicin—uterine cancer	9.79e-05	0.000421	CcSEcCtD
Diltiazem—Dyspnoea—Doxorubicin—uterine cancer	9.72e-05	0.000418	CcSEcCtD
Diltiazem—Feeling abnormal—Epirubicin—uterine cancer	9.71e-05	0.000418	CcSEcCtD
Diltiazem—Somnolence—Doxorubicin—uterine cancer	9.7e-05	0.000417	CcSEcCtD
Diltiazem—Dyspepsia—Doxorubicin—uterine cancer	9.6e-05	0.000413	CcSEcCtD
Diltiazem—Decreased appetite—Doxorubicin—uterine cancer	9.48e-05	0.000408	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.42e-05	0.000405	CcSEcCtD
Diltiazem—Fatigue—Doxorubicin—uterine cancer	9.4e-05	0.000405	CcSEcCtD
Diltiazem—Urticaria—Epirubicin—uterine cancer	9.36e-05	0.000403	CcSEcCtD
Diltiazem—Constipation—Doxorubicin—uterine cancer	9.33e-05	0.000401	CcSEcCtD
Diltiazem—Pain—Doxorubicin—uterine cancer	9.33e-05	0.000401	CcSEcCtD
Diltiazem—Abdominal pain—Epirubicin—uterine cancer	9.32e-05	0.000401	CcSEcCtD
Diltiazem—Body temperature increased—Epirubicin—uterine cancer	9.32e-05	0.000401	CcSEcCtD
Diltiazem—Feeling abnormal—Doxorubicin—uterine cancer	8.99e-05	0.000387	CcSEcCtD
Diltiazem—Hypersensitivity—Epirubicin—uterine cancer	8.68e-05	0.000374	CcSEcCtD
Diltiazem—Urticaria—Doxorubicin—uterine cancer	8.66e-05	0.000373	CcSEcCtD
Diltiazem—Abdominal pain—Doxorubicin—uterine cancer	8.62e-05	0.000371	CcSEcCtD
Diltiazem—Body temperature increased—Doxorubicin—uterine cancer	8.62e-05	0.000371	CcSEcCtD
Diltiazem—Asthenia—Epirubicin—uterine cancer	8.46e-05	0.000364	CcSEcCtD
Diltiazem—Pruritus—Epirubicin—uterine cancer	8.34e-05	0.000359	CcSEcCtD
Diltiazem—Diarrhoea—Epirubicin—uterine cancer	8.07e-05	0.000347	CcSEcCtD
Diltiazem—Hypersensitivity—Doxorubicin—uterine cancer	8.04e-05	0.000346	CcSEcCtD
Diltiazem—Asthenia—Doxorubicin—uterine cancer	7.83e-05	0.000337	CcSEcCtD
Diltiazem—Dizziness—Epirubicin—uterine cancer	7.79e-05	0.000335	CcSEcCtD
Diltiazem—Pruritus—Doxorubicin—uterine cancer	7.72e-05	0.000332	CcSEcCtD
Diltiazem—Vomiting—Epirubicin—uterine cancer	7.49e-05	0.000323	CcSEcCtD
Diltiazem—Diarrhoea—Doxorubicin—uterine cancer	7.46e-05	0.000321	CcSEcCtD
Diltiazem—Rash—Epirubicin—uterine cancer	7.43e-05	0.00032	CcSEcCtD
Diltiazem—Dermatitis—Epirubicin—uterine cancer	7.43e-05	0.00032	CcSEcCtD
Diltiazem—Headache—Epirubicin—uterine cancer	7.38e-05	0.000318	CcSEcCtD
Diltiazem—Dizziness—Doxorubicin—uterine cancer	7.21e-05	0.00031	CcSEcCtD
Diltiazem—Nausea—Epirubicin—uterine cancer	7e-05	0.000301	CcSEcCtD
Diltiazem—Vomiting—Doxorubicin—uterine cancer	6.93e-05	0.000298	CcSEcCtD
Diltiazem—Rash—Doxorubicin—uterine cancer	6.88e-05	0.000296	CcSEcCtD
Diltiazem—Dermatitis—Doxorubicin—uterine cancer	6.87e-05	0.000296	CcSEcCtD
Diltiazem—Headache—Doxorubicin—uterine cancer	6.83e-05	0.000294	CcSEcCtD
Diltiazem—Nausea—Doxorubicin—uterine cancer	6.48e-05	0.000279	CcSEcCtD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	1.91e-05	0.00258	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—ERBB2—uterine cancer	1.91e-05	0.00258	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.9e-05	0.00257	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MET—uterine cancer	1.86e-05	0.00251	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MET—uterine cancer	1.86e-05	0.00251	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	1.84e-05	0.00248	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	1.82e-05	0.00246	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKR1B1—uterine cancer	1.79e-05	0.00242	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—STAR—uterine cancer	1.79e-05	0.00242	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.78e-05	0.00241	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	1.77e-05	0.00239	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	1.74e-05	0.00235	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.73e-05	0.00234	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.68e-05	0.00227	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—SMAD3—uterine cancer	1.62e-05	0.00219	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	1.58e-05	0.00213	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.56e-05	0.00211	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.56e-05	0.0021	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	1.55e-05	0.0021	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.54e-05	0.00208	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.54e-05	0.00208	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.52e-05	0.00205	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.52e-05	0.00205	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—VEGFA—uterine cancer	1.47e-05	0.00198	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—NRAS—uterine cancer	1.45e-05	0.00196	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	1.45e-05	0.00196	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	1.44e-05	0.00194	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	1.43e-05	0.00193	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	1.42e-05	0.00191	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.41e-05	0.00191	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—POLD1—uterine cancer	1.4e-05	0.0019	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.37e-05	0.00186	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.37e-05	0.00186	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.37e-05	0.00185	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—ERBB2—uterine cancer	1.36e-05	0.00184	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—ERBB2—uterine cancer	1.36e-05	0.00184	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.33e-05	0.0018	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MET—uterine cancer	1.33e-05	0.00179	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.32e-05	0.00178	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKR1C1—uterine cancer	1.31e-05	0.00177	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.29e-05	0.00174	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.28e-05	0.00172	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.27e-05	0.00172	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.27e-05	0.00171	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.25e-05	0.00169	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.25e-05	0.00169	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.25e-05	0.00169	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—KRAS—uterine cancer	1.25e-05	0.00169	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.2e-05	0.00162	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CTNNB1—uterine cancer	1.19e-05	0.00161	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—RRM2—uterine cancer	1.17e-05	0.00158	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—DCN—uterine cancer	1.14e-05	0.00153	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.13e-05	0.00153	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—EP300—uterine cancer	1.11e-05	0.00149	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—STAR—uterine cancer	1.1e-05	0.00148	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.1e-05	0.00148	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.1e-05	0.00148	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.1e-05	0.00148	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.08e-05	0.00146	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP11A1—uterine cancer	1.07e-05	0.00145	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—HRAS—uterine cancer	1.06e-05	0.00143	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—VEGFA—uterine cancer	1.05e-05	0.00142	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—VEGFA—uterine cancer	1.05e-05	0.00142	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—NRAS—uterine cancer	1.04e-05	0.0014	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—NRAS—uterine cancer	1.03e-05	0.0014	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKR1C3—uterine cancer	1.01e-05	0.00137	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.01e-05	0.00136	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—ERBB2—uterine cancer	9.71e-06	0.00131	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SRD5A2—uterine cancer	9.49e-06	0.00128	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NDUFB11—uterine cancer	9.49e-06	0.00128	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	9.48e-06	0.00128	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	9.45e-06	0.00128	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	9.35e-06	0.00126	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.22e-06	0.00124	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.2e-06	0.00124	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—KRAS—uterine cancer	8.91e-06	0.0012	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—KRAS—uterine cancer	8.91e-06	0.0012	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.7e-06	0.00118	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—POLD1—uterine cancer	8.6e-06	0.00116	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—CTNNB1—uterine cancer	8.49e-06	0.00115	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SRD5A2—uterine cancer	8.47e-06	0.00114	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NDUFB11—uterine cancer	8.47e-06	0.00114	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NDUFB11—uterine cancer	8.27e-06	0.00112	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SRD5A2—uterine cancer	8.27e-06	0.00112	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.23e-06	0.00111	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKR1C1—uterine cancer	8.04e-06	0.00109	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	7.97e-06	0.00108	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKR1B1—uterine cancer	7.92e-06	0.00107	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—STAR—uterine cancer	7.92e-06	0.00107	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EP300—uterine cancer	7.89e-06	0.00107	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—STK11—uterine cancer	7.88e-06	0.00106	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP19A1—uterine cancer	7.88e-06	0.00106	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NDUFB11—uterine cancer	7.79e-06	0.00105	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SRD5A2—uterine cancer	7.79e-06	0.00105	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.77e-06	0.00105	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SRD5A2—uterine cancer	7.72e-06	0.00104	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NDUFB11—uterine cancer	7.72e-06	0.00104	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—HRAS—uterine cancer	7.57e-06	0.00102	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—HRAS—uterine cancer	7.57e-06	0.00102	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.5e-06	0.00101	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—VEGFA—uterine cancer	7.48e-06	0.00101	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—NRAS—uterine cancer	7.39e-06	0.000998	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—RRM2—uterine cancer	7.17e-06	0.000968	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.08e-06	0.000957	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—DCN—uterine cancer	6.96e-06	0.00094	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.93e-06	0.000937	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKR1B1—uterine cancer	6.86e-06	0.000927	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—STAR—uterine cancer	6.86e-06	0.000927	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.78e-06	0.000916	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—AKT1—uterine cancer	6.69e-06	0.000903	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP11A1—uterine cancer	6.56e-06	0.000885	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.42e-06	0.000868	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—KRAS—uterine cancer	6.36e-06	0.000859	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—POLD1—uterine cancer	6.21e-06	0.000839	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKR1C3—uterine cancer	6.19e-06	0.000836	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—STAR—uterine cancer	6.12e-06	0.000827	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKR1B1—uterine cancer	6.12e-06	0.000827	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.07e-06	0.00082	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.05e-06	0.000818	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—STAR—uterine cancer	5.98e-06	0.000807	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKR1B1—uterine cancer	5.98e-06	0.000807	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—MTHFR—uterine cancer	5.92e-06	0.000799	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.91e-06	0.000799	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKR1C1—uterine cancer	5.81e-06	0.000785	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.64e-06	0.000762	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—STAR—uterine cancer	5.63e-06	0.000761	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKR1B1—uterine cancer	5.63e-06	0.000761	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKR1B1—uterine cancer	5.58e-06	0.000754	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—STAR—uterine cancer	5.58e-06	0.000754	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.52e-06	0.000745	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—HRAS—uterine cancer	5.4e-06	0.00073	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—POLD1—uterine cancer	5.38e-06	0.000727	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.34e-06	0.000722	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—RRM2—uterine cancer	5.18e-06	0.0007	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.09e-06	0.000688	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.09e-06	0.000688	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKR1C1—uterine cancer	5.03e-06	0.00068	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—DCN—uterine cancer	5.03e-06	0.000679	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—STK11—uterine cancer	4.82e-06	0.000651	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP19A1—uterine cancer	4.82e-06	0.000651	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—POLD1—uterine cancer	4.8e-06	0.000649	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—AKT1—uterine cancer	4.77e-06	0.000644	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP11A1—uterine cancer	4.74e-06	0.00064	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—POLD1—uterine cancer	4.69e-06	0.000633	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.54e-06	0.000613	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKR1C1—uterine cancer	4.49e-06	0.000607	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—RRM2—uterine cancer	4.49e-06	0.000606	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKR1C3—uterine cancer	4.47e-06	0.000604	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—POLD1—uterine cancer	4.42e-06	0.000597	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKR1C1—uterine cancer	4.39e-06	0.000593	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—POLD1—uterine cancer	4.38e-06	0.000592	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—DCN—uterine cancer	4.36e-06	0.000588	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.17e-06	0.000564	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKR1C1—uterine cancer	4.13e-06	0.000558	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP11A1—uterine cancer	4.1e-06	0.000554	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKR1C1—uterine cancer	4.1e-06	0.000554	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.04e-06	0.000545	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—RRM2—uterine cancer	4.01e-06	0.000541	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—RRM2—uterine cancer	3.91e-06	0.000528	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—DCN—uterine cancer	3.89e-06	0.000525	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.88e-06	0.000524	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—DCN—uterine cancer	3.8e-06	0.000513	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—RRM2—uterine cancer	3.68e-06	0.000498	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—STAR—uterine cancer	3.68e-06	0.000497	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.68e-06	0.000497	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP11A1—uterine cancer	3.66e-06	0.000495	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—RRM2—uterine cancer	3.65e-06	0.000493	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—MTHFR—uterine cancer	3.62e-06	0.00049	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—DCN—uterine cancer	3.58e-06	0.000483	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP11A1—uterine cancer	3.58e-06	0.000483	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—DCN—uterine cancer	3.55e-06	0.000479	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—STK11—uterine cancer	3.49e-06	0.000471	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.49e-06	0.000471	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKR1C3—uterine cancer	3.46e-06	0.000467	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.41e-06	0.00046	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKR1C3—uterine cancer	3.38e-06	0.000456	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP11A1—uterine cancer	3.37e-06	0.000455	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.34e-06	0.000451	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTEN—uterine cancer	3.29e-06	0.000445	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKR1C3—uterine cancer	3.18e-06	0.00043	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKR1C3—uterine cancer	3.15e-06	0.000426	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—EP300—uterine cancer	3.14e-06	0.000424	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—STK11—uterine cancer	3.02e-06	0.000408	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP19A1—uterine cancer	3.02e-06	0.000408	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—POLD1—uterine cancer	2.89e-06	0.00039	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.83e-06	0.000383	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.7e-06	0.000365	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.7e-06	0.000365	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—STK11—uterine cancer	2.7e-06	0.000364	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.7e-06	0.000364	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—STK11—uterine cancer	2.63e-06	0.000355	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP19A1—uterine cancer	2.63e-06	0.000355	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—MTHFR—uterine cancer	2.62e-06	0.000354	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.53e-06	0.000342	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.48e-06	0.000335	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—STK11—uterine cancer	2.48e-06	0.000335	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.46e-06	0.000332	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—STK11—uterine cancer	2.46e-06	0.000332	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.41e-06	0.000326	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—RRM2—uterine cancer	2.41e-06	0.000325	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—DCN—uterine cancer	2.34e-06	0.000316	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CA—uterine cancer	2.32e-06	0.000314	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.31e-06	0.000312	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—MTHFR—uterine cancer	2.27e-06	0.000307	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.2e-06	0.000298	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.2e-06	0.000297	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.08e-06	0.000281	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—MTHFR—uterine cancer	2.03e-06	0.000274	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTEN—uterine cancer	2.02e-06	0.000272	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2e-06	0.00027	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—MTHFR—uterine cancer	1.98e-06	0.000267	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—EP300—uterine cancer	1.92e-06	0.00026	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKT1—uterine cancer	1.9e-06	0.000256	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—MTHFR—uterine cancer	1.86e-06	0.000252	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—MTHFR—uterine cancer	1.85e-06	0.000249	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.78e-06	0.000241	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.63e-06	0.00022	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.62e-06	0.000219	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—STK11—uterine cancer	1.62e-06	0.000219	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTEN—uterine cancer	1.46e-06	0.000197	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.42e-06	0.000192	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—EP300—uterine cancer	1.39e-06	0.000188	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTEN—uterine cancer	1.26e-06	0.000171	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—MTHFR—uterine cancer	1.22e-06	0.000165	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—EP300—uterine cancer	1.2e-06	0.000163	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKT1—uterine cancer	1.16e-06	0.000157	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTEN—uterine cancer	1.13e-06	0.000152	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTEN—uterine cancer	1.1e-06	0.000149	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—EP300—uterine cancer	1.07e-06	0.000145	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—EP300—uterine cancer	1.05e-06	0.000142	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTEN—uterine cancer	1.04e-06	0.00014	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.03e-06	0.000139	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTEN—uterine cancer	1.03e-06	0.000139	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—EP300—uterine cancer	9.88e-07	0.000134	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—EP300—uterine cancer	9.8e-07	0.000132	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CA—uterine cancer	8.91e-07	0.00012	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKT1—uterine cancer	8.4e-07	0.000113	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CA—uterine cancer	7.95e-07	0.000107	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CA—uterine cancer	7.76e-07	0.000105	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CA—uterine cancer	7.31e-07	9.88e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKT1—uterine cancer	7.27e-07	9.83e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CA—uterine cancer	7.25e-07	9.79e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTEN—uterine cancer	6.78e-07	9.15e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKT1—uterine cancer	6.49e-07	8.77e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—EP300—uterine cancer	6.46e-07	8.73e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKT1—uterine cancer	6.34e-07	8.56e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKT1—uterine cancer	5.97e-07	8.07e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKT1—uterine cancer	5.92e-07	8e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.78e-07	6.46e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKT1—uterine cancer	3.9e-07	5.27e-05	CbGpPWpGaD
